middle.news
How Cleo Diagnostics Is Advancing Early Ovarian Cancer Detection in 2025
9:18am on Monday 21st of July, 2025 AEST
•
Healthcare
Read Story
How Cleo Diagnostics Is Advancing Early Ovarian Cancer Detection in 2025
9:18am on Monday 21st of July, 2025 AEST
Key Points
U.S. clinical trial recruitment progressing, targeting Q4 2025 completion
Alpha testing of diagnostic assay successfully completed
Access granted to PLCO and UKCTOCS biobanks for pivotal studies
Received A$845k R&D tax incentive for FY24
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Cleo Diagnostics (ASX:COV)
OPEN ARTICLE